Immunitybio Inc (IBRX)

R&D Expenses

$57.69M

Quarterly · Period ending: · USD

IBRX logo

IBRX R&D Expenses

Latest reported$57.69M
IBRX Quarterly R&D Expenses ($1.75M → $57.69M)
High-resolution chart · PNG

IBRX r&d expenses history

Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.

Immunitybio Inc R&D Expenses — Quarterly (USD)
Period endingR&D Expenses (USD)
57,690,000
64,770,000
60,808,000
50,732,000
55,236,000
48,234,000
35,221,000
50,443,000
51,129,000
53,351,000
51,532,000
48,402,000
53,168,000
78,764,000
52,851,000
67,112,000
58,638,000
51,288,000
51,753,000
49,277,000
53,800,000
41,128,000
20,256,000
35,772,000
33,005,000
27,374,000
13,193,000
12,052,000
13,131,000
12,598,000
12,480,000
14,559,000
14,688,000
13,991,000
12,021,000
11,069,000
9,706,000
9,248,000
9,445,000
8,364,000
6,389,000
4,944,000
5,106,000
3,950,000
1,745,000
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.